# EDGAR Filing Document

**Accession Number:** 0001690947
**File Stem:** 0001157523-23-000430
**Filing Date:** 2023-3
**Character Count:** 5131
**Document Hash:** e5734baa8ea9a993b7bfb3b404d208ad
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001157523-23-000430.hdr.sgml**: 20230314

**ACCESSION NUMBER**: 0001157523-23-000430

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230314

**FILED AS OF DATE**: 20230314

**DATE AS OF CHANGE**: 20230314

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEXO Corp.
- **CENTRAL INDEX KEY:** 0001690947
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A8
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38781
- **FILM NUMBER:** 23729150

**BUSINESS ADDRESS:**
- **STREET 1:** 120 CHEMIN DE LA RIVE
- **CITY:** GATINEAU
- **STATE:** A8
- **ZIP:** J8M 1V2
- **BUSINESS PHONE:** 1-844-406-1852

**MAIL ADDRESS:**
- **STREET 1:** 120 CHEMIN DE LA RIVE
- **CITY:** GATINEAU
- **STATE:** A8
- **ZIP:** J8M 1V2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hydropothecary Corp
- **DATE OF NAME CHANGE:** 20161128

#### UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION <br> Washington, D.C. 20549
&nbsp;&nbsp;&nbsp;&nbsp;<br>

### FORM 6-K
&nbsp;&nbsp;&nbsp;&nbsp;<br>

#### REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE<br> SECURITIES EXCHANGE ACT OF 1934

#### For the month of March 2023<br>
&nbsp;&nbsp;&nbsp;&nbsp;<br>

Commission File Number: **001-38781**

**HEXO Corp.**<br> (Translation of registrant's name into English)<br>

**120 chemin de la Rive**<br> **Gatineau, Québec, Canada J8M 1V2**<br> (Address of principal executive office)<br>

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.<br> Form 20-F [ ] Form 40-F [ X ]<br>

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐<br>

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

---

| | |
|:---|:---|
| **<u>Exhibit</u>** | **<u>Description</u>** |
| [99.1](a53361653ex99_1.htm) | [Press release dated March 14, 2023](a53361653ex99_1.htm)<br>|

---

------

#### <br>

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **HEXO Corp.** |
| Date: March 14, 2023<br>| /s/ *Julius Ivancsits* |
|  | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**<br>

# **HEXO to Host Second Quarter 2023 Earnings Conference Call** 
 ***This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021*** 

GATINEAU, Québec--(BUSINESS WIRE)--March 14, 2023--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the "Company"), a leading producer of high-quality cannabis products, announced today that it will hold an audio only conference call on March 17, 2023, at 10 a.m. EDT, to review its financial results for the second fiscal quarter, ended January 31, 2023. The results will be released after market close on Thursday, March 16, 2023.

Following the prepared remarks, there will be a question-and-answer session. Charlie Bowman, President & Chief Executive Officer, and Julius Ivancsits, Chief Financial Officer, will be participating on the call.

 **<u>Conference Call Details</u>** <br> Date: Friday, March 17, 2023 <br> Time: 10 a.m. EDT <br> Participant Toll-Free Dial-In Number: +1 888-440-5584 <br> Participant Toll Dial-In Number: +1 646-960-0457 <br> Conference ID: 6142858

Please dial-in 15 minutes before the start of the conference to secure a line and avoid delays. This conference call will be recorded and available for replay two hours after the call's completion until April 11, 2023, at 11:59 p.m. EDT.

To listen to the replay, please use the dial-in number listed below and the conference ID:

Toll Free Dial-in Number: +1 800-770-2030 <br> Toll Dial-in Number: +1 647-362-9199

 **About HEXO Corp.** <br> HEXO is an award-winning licensed producer of premium products for the global cannabis market. HEXO delivers a thoughtfully curated portfolio of both recreational and therapeutic cannabis products that inspire customer loyalty. HEXO's brands include HEXO, Redecan, Original Stash, Bake Sale and T 2.0, as well as medical cannabis products.

HEXO's world-class Canadian grow sites are unmatched in size, technological advantage and yield of high-quality cannabis, driving innovation through every step of the process. HEXO operates three major grow sites in Ontario and Québec, including one of the largest facilities in North America. HEXO Corp. is a publicly traded company under the tickers (TSX: HEXO) and (NASDAQ:HEXO).

## Contacts
 **For media or investor inquiries:** <br> Hayley Suchanek, Kaiser & Partners <br> hayley.suchanek@kaiserpartners.com